AngioScore Inks $30M Round

Fremont, California-based AngioScore said today that it has completed $30M in a Series E funding round. The funding came from Telegraph Hill Partners, which led the round, along with prior investors Psilos Group Management, QuestMark Partners, L.P., UV Partners, California Technology Ventures and Innomed Ventures. AngioScore said it will use the funds for its sales effort, expanding manufacturing operations, and accelerating product development. AngioScore develops angioplasty catheters for the healthcare market. More information »